Literature DB >> 19176419

Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study.

Robert Hunter1, Rosie Cameron, John Norrie.   

Abstract

OBJECTIVE: The primary aim of the Scottish Schizophrenia Outcomes Study (SSOS) was to assess the feasibility and utility of routinely collecting outcome data in everyday clinical settings. Data were collected over three years in the Scottish National Health Service (NHS). There were two secondary aims of SSOS: first, to compare data from patient-rated, objective, and clinician-rated outcomes, and second, to describe trends in outcome data and service use across Scotland over the three years of the study (2002-2005).
METHODS: This study used a naturalistic, longitudinal, observational cohort design. A representative sample of 1,015 persons with ICD-10 F20-F29 diagnoses (schizophrenia, schizotypal disorders, or delusional disorders) was assessed annually using the clinician-rated measure, the Health of the Nation Outcome Scale (HoNOS), and the patient-reported assessment, the Avon Mental Health Measure (Avon). Objective outcomes data and information on services and interventions were collected. Data were analyzed with regression modeling.
RESULTS: Of the 1,015 persons recruited, 78% of the cohort (N=789) completed the study. Over the study period, significant decreases were seen in the number of hospitalizations, incidence of attempted suicide and self-harm, and civil detentions. Avon scores indicated significant improvement on all subscales (behavior, social, access, and mental health) and on the total score. However, HoNOS scores on the behavior and symptom subscales did not change, scores on the impairment subscale increased significantly (indicating increased levels of impairment), and scores on the social subscale decreased significantly (indicating improved social functioning).
CONCLUSIONS: This study has demonstrated that it is feasible within the Scottish NHS to routinely collect meaningful outcomes data in schizophrenia. Patient-reported assessments were also successfully collected and used in care plans. This model shows that it is possible to incorporate patient-reported assessments into routine care for schizophrenia. Such assessments may provide useful data for clinicians and may improve treatment adherence. The pattern of outcomes and interventions confirms that despite the introduction of guidelines, new treatments, and new services, people with schizophrenia continue to have high levels of chronic disability.

Entities:  

Mesh:

Year:  2009        PMID: 19176419     DOI: 10.1176/ps.2009.60.2.240

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  13 in total

1.  Using Routine Outcome Measures to Provide Feedback at the Service Agency Level.

Authors:  David Roe; Liron Lapid; Vered Baloush-Kleinman; Paula Garber-Epstein; Miriam Isolde Gornemann; Marc Gelkopf
Journal:  Community Ment Health J       Date:  2016-06-20

2.  The incremental value of self-reported mental health measures in predicting functional outcomes of veterans.

Authors:  Susan V Eisen; Kathryn A Bottonari; Mark E Glickman; Avron Spiro; Mark R Schultz; Lawrence Herz; Robert Rosenheck; Ethan S Rofman
Journal:  J Behav Health Serv Res       Date:  2011-04       Impact factor: 1.505

3.  Clozapine-induced interstitial nephritis - a rare but important complication: a case report.

Authors:  Robert Hunter; Tracey Gaughan; Filippo Queirazza; Dina McMillan; Susan Shankie
Journal:  J Med Case Rep       Date:  2009-08-27

4.  The impact of co-morbid personality disorder on use of psychiatric services and involuntary hospitalization in people with severe mental illness.

Authors:  Marcella Lei-Yee Fok; Robert Stewart; Richard D Hayes; Paul Moran
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-04-09       Impact factor: 4.328

5.  Functional status and all-cause mortality in serious mental illness.

Authors:  Richard D Hayes; Chin-Kuo Chang; Andrea C Fernandes; Aysha Begum; David To; Matthew Broadbent; Matthew Hotopf; Robert Stewart
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

6.  Outcomes that matter: a qualitative study with persons with schizophrenia and their primary caregivers in India.

Authors:  Madhumitha Balaji; Sudipto Chatterjee; Beth Brennan; Thara Rangaswamy; Graham Thornicroft; Vikram Patel
Journal:  Asian J Psychiatr       Date:  2012-07-28

7.  Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia.

Authors:  Jorge Mauriño; Julio Sanjúan; Josep Maria Haro; Teresa Díez; Javier Ballesteros
Journal:  Patient Prefer Adherence       Date:  2011-09-27       Impact factor: 2.711

8.  The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders.

Authors:  Richard D Hayes; Johnny Downs; Chin-Kuo Chang; Richard G Jackson; Hitesh Shetty; Matthew Broadbent; Matthew Hotopf; Robert Stewart
Journal:  Schizophr Bull       Date:  2014-08-25       Impact factor: 9.306

9.  Predictors of natural and unnatural mortality among patients with personality disorder: evidence from a large UK case register.

Authors:  Marcella Lei-Yee Fok; Robert Stewart; Richard D Hayes; Paul Moran
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

10.  A short-term, multicenter, placebo-controlled, randomized withdrawal study of a metabotropic glutamate 2/3 receptor agonist using an electronic patient-reported outcome device in patients with schizophrenia.

Authors:  Virginia L Stauffer; Simin K Baygani; Bruce J Kinon; Judith O Krikke-Workel
Journal:  J Clin Psychopharmacol       Date:  2014-10       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.